Acute myocardial infarction onset ischemia time. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Myocardium Coronary Vessels Heart Heart Ventricles Biliary Tract Transplants Myocytes, Cardiac Kidney Bile Ducts Hepatic Artery

Organisms3

Rats, Sprague-Dawley Rats, Wistar Dogs

Diseases68

Myocardial Infarction Ischemia Myocardial Ischemia Infarction Brain Ischemia Anterior Wall Myocardial Infarction Cerebral Infarction Ventricular Remodeling Delayed Graft Function Shock, Cardiogenic Acute Disease Angina Pectoris Reperfusion Injury Coronary Disease Angina, Unstable Death Coronary Thrombosis Chest Pain Recurrence Myocardial Reperfusion Injury Ventricular Dysfunction, Left Coronary Artery Disease Arrhythmias, Cardiac Disease Models, Animal Heart Failure Heart Rupture, Post-Infarction Cadaver Postoperative Complications Hemorrhage Stroke Inferior Wall Myocardial Infarction Acute Coronary Syndrome Edema, Cardiac Thrombosis Death, Sudden, Cardiac Heart Rupture Ventricular Septal Rupture No-Reflow Phenomenon Ventricular Fibrillation Coronary Occlusion Coronary Stenosis Diabetes Complications Brain Death Heart Diseases Coronary Vasospasm Cardiovascular Diseases Necrosis Ischemic Attack, Transient Emergencies Cerebrovascular Disorders Heart Aneurysm Death, Sudden Embolism Coronary Restenosis Rupture, Spontaneous Primary Graft Dysfunction Infarction, Middle Cerebral Artery Biliary Tract Diseases Diabetic Angiopathies Liver Failure Kidney Tubular Necrosis, Acute Diabetes Mellitus Hypertension Cardiac Complexes, Premature Convalescence Bundle-Branch Block Myocardial Stunning Tachycardia, Ventricular

Chemicals and Drugs44

Streptokinase Creatine Kinase Fibrinolytic Agents Platelet Aggregation Inhibitors Tissue Plasminogen Activator Biological Markers Troponin T Aspirin Troponin I Adrenergic beta-Antagonists Cardiotonic Agents Anistreplase Organ Preservation Solutions Creatine Kinase, MB Form Raffinose Heparin Cardiovascular Agents Immunoglobulin Fab Fragments Anticoagulants Ticlopidine Technetium Tc 99m Sestamibi Angiotensin-Converting Enzyme Inhibitors Thallium Radioisotopes Platelet Glycoprotein GPIIb-IIIa Complex Technetium Tc 99m Pyrophosphate Isoenzymes Troponin Contrast Media Myoglobin Nicorandil Iodobenzenes Natriuretic Peptide, Brain L-Lactate Dehydrogenase Allopurinol Dobutamine Creatinine C-Reactive Protein Plasminogen Activators Hydroxybutyrate Dehydrogenase Hirudins Hydroxymethylglutaryl-CoA Reductase Inhibitors Tocainide Radiopharmaceuticals Immunosuppressive Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment94

Cold Ischemia Warm Ischemia Thrombolytic Therapy Angioplasty, Balloon, Coronary Electrocardiography Myocardial Reperfusion Coronary Angiography Treatment Outcome Risk Factors Prospective Studies Organ Preservation Follow-Up Studies Retrospective Studies Prognosis Hospital Mortality Predictive Value of Tests Stents Myocardial Revascularization Nephrectomy Stroke Volume Risk Assessment Echocardiography Kidney Transplantation Liver Transplantation Survival Analysis Percutaneous Coronary Intervention Tissue and Organ Harvesting Multivariate Analysis Hospitalization Clinical Enzyme Tests Survival Rate Registries Disease Models, Animal Coronary Artery Bypass Cardiac Catheterization Incidence Proportional Hazards Models Chi-Square Distribution Cohort Studies Case-Control Studies Kaplan-Meier Estimate Logistic Models Tomography, Emission-Computed, Single-Photon Length of Stay Thrombectomy Risk Intra-Aortic Balloon Pumping Odds Ratio Drug-Eluting Stents Sensitivity and Specificity Exercise Test Electrocardiography, Ambulatory Double-Blind Method Regression Analysis Pancreas Transplantation Heart Rate Severity of Illness Index Laparoscopy Randomized Controlled Trials as Topic Ischemic Preconditioning, Myocardial Drug Therapy, Combination Heart Function Tests Patient Admission Magnetic Resonance Imaging, Cine Patient Selection Patient Transfer Reperfusion Analysis of Variance Patient Discharge Angioplasty Blood Pressure Magnetic Resonance Imaging Cause of Death Random Allocation Hirudin Therapy Confidence Intervals Transportation of Patients Ultrasonography, Interventional ROC Curve Vectorcardiography Infusions, Intravenous Suction Cineangiography Ligation Tomography, X-Ray Computed Tissue Preservation Gated Blood-Pool Imaging Emergency Treatment Echocardiography, Doppler Donor Selection Radionuclide Ventriculography Time-to-Treatment Feasibility Studies Assisted Circulation

Psychiatry and Psychology1

Phenomena and Processes23

Time Factors Ventricular Remodeling Ventricular Function, Left Coronary Circulation Graft Survival Stroke Volume Chi-Square Distribution Hemodynamics Myocardial Contraction Tissue Survival Risk Odds Ratio Sensitivity and Specificity Heart Rate Necrosis Vascular Patency Graft Rejection Blood Pressure Microcirculation Recovery of Function Collateral Circulation Systole Neovascularization, Physiologic

Disciplines and Occupations3

Robotics Cardiology Outcome Assessment (Health Care)

Technology, Industry, Agriculture2

Robotics Ambulances

Information Science6

Hospital Mortality Survival Rate Registries Incidence Robotics Cause of Death

Named Groups2

Tissue Donors Living Donors

Health Care54

Treatment Outcome Risk Factors Coronary Care Units Prospective Studies Follow-Up Studies Retrospective Studies Hospital Mortality Predictive Value of Tests Risk Assessment Survival Analysis Multivariate Analysis Hospitalization Survival Rate Tissue and Organ Procurement Registries Incidence Proportional Hazards Models Age Factors Chi-Square Distribution Cohort Studies Case-Control Studies Kaplan-Meier Estimate Logistic Models Emergency Medical Services Sex Factors Length of Stay Risk Odds Ratio Sensitivity and Specificity Double-Blind Method Regression Analysis Cardiology Service, Hospital Severity of Illness Index Randomized Controlled Trials as Topic Patient Admission Patient Selection Patient Transfer Analysis of Variance Patient Discharge Emergencies Cause of Death Random Allocation Confidence Intervals Transportation of Patients ROC Curve Comorbidity Ambulances Emergency Service, Hospital Outcome Assessment (Health Care)Medicare Hospitals Donor Selection Time-to-Treatment Feasibility Studies

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Myocardial Infarction Cold Ischemia Warm Ischemia Ischemia Time Factors Thrombolytic Therapy Angioplasty, Balloon, Coronary Electrocardiography Myocardial Reperfusion Myocardial Ischemia Coronary Angiography Streptokinase Treatment Outcome Infarction Creatine Kinase Risk Factors Coronary Care Units Prospective Studies Brain Ischemia Organ Preservation Anterior Wall Myocardial Infarction Fibrinolytic Agents Follow-Up Studies Cerebral Infarction Ventricular Remodeling Retrospective Studies Delayed Graft Function Myocardium Ventricular Function, Left Shock, Cardiogenic Acute Disease Prognosis Hospital Mortality Angina Pectoris Coronary Circulation Tissue Donors Predictive Value of Tests Graft Survival Reperfusion Injury Coronary Disease Stents Myocardial Revascularization Coronary Vessels Angina, Unstable Death Coronary Thrombosis Nephrectomy Stroke Volume Chest Pain Risk Assessment Platelet Aggregation Inhibitors Recurrence Echocardiography Tissue Plasminogen Activator Kidney Transplantation Myocardial Reperfusion Injury Ventricular Dysfunction, Left Biological Markers Liver Transplantation Survival Analysis Heart Percutaneous Coronary Intervention Tissue and Organ Harvesting Multivariate Analysis Hospitalization Coronary Artery Disease Clinical Enzyme Tests Survival Rate Arrhythmias, Cardiac Tissue and Organ Procurement Registries Disease Models, Animal Coronary Artery Bypass Heart Failure Troponin T Heart Rupture, Post-Infarction Cardiac Catheterization Cadaver Aspirin Heart Ventricles Incidence Living Donors Proportional Hazards Models Age Factors Chi-Square Distribution Cohort Studies Troponin I Adrenergic beta-Antagonists Hemodynamics Biliary Tract Cardiotonic Agents Anistreplase Postoperative Complications Case-Control Studies Organ Preservation Solutions Kaplan-Meier Estimate Hemorrhage Stroke Creatine Kinase, MB Form Logistic Models

No FAQ available that match "acute myocardial infarction onset ischemia time"